Blockchain Registration Transaction Record
Pacylex Pharmaceuticals to Showcase Advances in Cancer Therapies at Industry Conferences
Pacylex Pharmaceuticals showcases progress in cancer therapies at industry conferences, including oral zelenirstat development for heme cancers and NMTis as ADC payloads. Learn about the innovative advancements in precision medicine and potential impact on patient outcomes.
This news matters as it highlights the innovative work of Pacylex Pharmaceuticals in developing targeted therapies for cancer. The presentation of progress in clinical development of oral zelenirstat and other NMTis as ADC payloads showcases potential advancements in cancer treatment, impacting the future of precision medicine and patient outcomes.
Blockchain | Details |
---|---|
Contract Address | 0x0553B273B8eBf464Bd2a37C259F0eEBb3d70Fd71 |
Transaction ID | 0x1f4cb80b7b6100ea50366bd1a5c889518b0a0f080c49b7f11f904f9badf6f8d7 |
Account | 0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20 |
Chain | polygon-main |
NewsRamp Digital Fingerprint | gulfgnYW-6b3cdb9498b77dffd321afb127700e2e |